Corona Remedies Share Price Today (15 Dec 2025): Pharma Stock Debuts at 38% Premium After ₹655-Crore IPO — Latest News, Forecasts, Valuation and Analyst Views
Corona Remedies shares debuted at ₹1,470 on NSE, a 38% premium to the IPO price of ₹1,062. The stock surged intraday to nearly ₹1,499 and hovered around the mid-₹1,460s by early afternoon, valuing the company near ₹9,000 crore. Trading volumes reached millions of shares. The listing beat grey market forecasts, which had predicted a 28–32% premium.
